These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 6979550)

  • 1. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
    Okano K; Furukawa Y; Morii H; Fujita T
    J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
    J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypoparathyroidism with 1 alpha-hydroxyvitamin D3].
    Meng XW; Xing XP; Zhou XY
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):350-2, 383. PubMed ID: 2269035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic application of vitamin D, its derivatives and analogues (author's transl)].
    Balsan S
    Ann Endocrinol (Paris); 1981; 42(4-5):492-6. PubMed ID: 6896128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
    Furukawa Y; Sohn H; Unakami H; Yumita S
    Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Various types of hypoparathyroidism and their treatment].
    Okano K; Nakai R; Tomori T; Yoshikawa M
    Horumon To Rinsho; 1978 Apr; 26(4):371-7. PubMed ID: 306900
    [No Abstract]   [Full Text] [Related]  

  • 8. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
    Mizunashi K; Furukawa Y; Goto MM; Abe K
    Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapy of hypoparathyroidism--a survey of German endocrinology centers.
    Schilling T; Ziegler R
    Exp Clin Endocrinol Diabetes; 1997; 105(4):237-41. PubMed ID: 9285213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
    Chan JC; Young RB; Hartenberg MA; Chinchilli VM
    J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Oct; 51(4):823-9. PubMed ID: 6968318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
    Yamamoto M; Takuwa Y; Masuko S; Ogata E
    J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D therapy in hypoparathyroidism and pseudohypoparathyroidism: weight-related dosages for initiation of therapy and maintenance therapy.
    Kind HP; Handysides A; Kooh SW; Fraser D
    J Pediatr; 1977 Dec; 91(6):1006-10. PubMed ID: 303694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of hypoparathyroidism with 1alpha-hydroxyvitamin D3.
    Heyburn PJ; Peacock M
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():209s-214s. PubMed ID: 606418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoparathyroidism and pseudohypoparathyroidism.
    Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolism in hypoparathyroidism.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.